Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Submitted by
admin
on January 17, 2015 - 4:01pm
Source:
Bidness Etc.
News Tags:
Amgen
Vectibix
metastatic colorectal cancer
mCRC
Headline:
Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Do Not Allow Advertisers to Use My Personal information
